BCWORLD PHARM. Co., Ltd. (KOSDAQ:200780)

BCWORLD PHARM. Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	4,676	5,444	6,996	4,032	2,756	10,681
Short-Term Investments	2,467	2,467	4,170	4,025	1,746	1,880
Cash & Short-Term Investments	7,143	7,911	11,166	8,058	4,503	12,561
Cash Growth	-14.00%	-29.14%	38.57%	78.97%	-64.15%	263.45%
Accounts Receivable	16,050	20,297	18,190	16,511	15,047	-
Other Receivables	624.08	589.67	648.15	1,267	880.31	-
Receivables	16,674	20,887	19,483	17,778	15,927	-
Inventory	18,195	14,844	17,096	16,787	16,147	15,370
Prepaid Expenses	1,096	911.85	250.24	406.41	363.9	-
Other Current Assets	186.41	3.72	91.07	579.46	294.04	15,133
Total Current Assets	43,294	44,558	48,086	43,609	37,235	43,063
Property, Plant & Equipment	119,688	120,985	125,628	130,119	132,370	125,500
Long-Term Investments	2,999	2,921	1,784	1,362	3,756	-
Other Intangible Assets	2,672	2,711	2,997	2,828	2,266	1,175
Long-Term Deferred Tax Assets	4,889	4,946	5,459	4,979	3,145	2,268
Other Long-Term Assets	190.89	192.37	157.07	154.27	586.78	4,919
Total Assets	173,733	176,313	184,111	183,051	179,358	176,925
Accounts Payable	5,246	3,872	4,232	4,067	2,686	-
Accrued Expenses	4,000	3,915	425.32	456.14	556.95	-
Short-Term Debt	67,585	68,606	58,216	46,050	39,730	-
Current Portion of Long-Term Debt	11,493	5,653	21,433	26,817	5,405	-
Current Portion of Leases	270.25	256.72	196.82	62.87	66.58	-
Current Income Taxes Payable	61.52	84.71	136.93	-	133.13	-
Other Current Liabilities	3,916	3,477	7,606	6,753	7,314	56,160
Total Current Liabilities	92,573	85,865	92,246	84,206	55,892	56,160
Long-Term Debt	7,083	13,917	11,570	21,170	43,686	-
Long-Term Leases	485.21	521.27	424.88	154.87	132.15	-
Other Long-Term Liabilities	-0	-0	0	0	-0	37,198
Total Liabilities	100,141	100,303	104,241	105,531	99,711	93,357
Common Stock	1,778	1,778	1,778	1,778	1,778	1,778
Additional Paid-In Capital	34,947	34,947	34,947	34,947	34,947	34,947
Retained Earnings	38,755	41,520	46,495	44,404	45,255	48,106
Treasury Stock	-1,578	-1,578	-1,578	-1,578	-771.62	-771.62
Comprehensive Income & Other	168.77	-0	-0	-0	248.54	100.65
Total Common Equity	74,071	76,668	81,643	79,552	81,458	84,161
Minority Interest	-479.14	-657.38	-1,774	-2,032	-1,811	-593.29
Shareholders' Equity	73,592	76,010	79,869	77,520	79,647	83,568
Total Liabilities & Equity	173,733	176,313	184,111	183,051	179,358	176,925
Total Debt	86,917	88,954	91,841	94,255	89,021	-
Net Cash (Debt)	-79,775	-81,043	-80,675	-86,197	-84,518	12,561
Net Cash Per Share	-8584.66	-8730.77	-8691.15	-9194.93	-8998.56	1341.96
Filing Date Shares Outstanding	8.44	9.28	9.28	9.28	9.39	9.39
Total Common Shares Outstanding	8.44	9.28	9.28	9.28	9.39	9.39
Working Capital	-49,279	-41,307	-44,161	-40,597	-18,658	-13,096
Book Value Per Share	8777.66	8259.46	8795.44	8570.17	8672.71	8960.53
Tangible Book Value	71,399	73,957	78,646	76,724	79,192	82,986
Tangible Book Value Per Share	8461.01	7967.44	8472.57	8265.56	8431.48	8835.45
Land	17,138	17,138	17,138	17,138	11,773	11,608
Buildings	69,474	70,030	71,974	73,792	51,199	56,229
Machinery	26,445	27,259	30,345	33,654	36,336	40,799
Construction In Progress	1,086	983.43	278.23	593.43	28,346	13,296

Source: S&P Global Market Intelligence. Standard template. Financial Sources.